Table 6.
Invasive test results of 3 false-negative NIPT samples
| Sampling site | Karyotype | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Placenta | case 1 | case 2 | case 3 | ||||||
| Fetal surface | 0 | T21 (10% mos) | 46, XN | T18 (40% mos) | |||||
| 3 | T21 (23% mos) | 46, XN | T18 | ||||||
| 6 | T21 | 46, XN | T18 | ||||||
| 9 | T21 (58% mos) | 46, XN | T18 | ||||||
| Central | T21 | 46, XN | T18 | ||||||
| Maternal surface | 0 | T21 | 46, XN | T18 (37% mos) | |||||
| 3 | T21 (31% mos) | 46, XN | T18 (56% mos) | ||||||
| 6 | T21 | 46, XN | T18 (41% mos) | ||||||
| 9 | T21 | 46, XN | T18 (49% mos) | ||||||
| Central | T21 | 46, XN | T18 (46% mos) | ||||||
| Fetus | Muscle | T21 | T21 | T18 | |||||
| Skin | T21 | T21 | T18 |
Mos Mosaic, N X or Y, T21 Trisomy 21, T18, Trisomy 18; 0, 3, 6, 9, and central: the tissue sampling sites according to the Clock face notation